A measure of brain activity known as causal flow can help locate the source of epilepsy seizures before they occur, according to a new study.
NeuralTree: a closed-loop neuromodulation system-on-chip that can detect and alleviate disease symptoms. Thanks to a 256-channel high-resolution sensing array and an energy-efficient machine learning processor, the system can extract and classify a broad set of biomarkers from real patient data and animal models of disease in-vivo, leading to a high degree of accuracy in symptom prediction.
Fintepla (fenfluramine) is associated with dose-dependent, clinically meaningful improvements in everyday behavioral and emotional control, as well as the ability to adapt to new situations, in preschool-aged children with Dravet syndrome.
Inpatient falls within the Epilepsy Monitoring Unit (EMU) are a common, and potentially preventable adverse event contributing to morbidity for patients living with epilepsy. Accurate fall risk screening is important to identify and efficiently allocate proper safety measures to high-risk patients, especially in EMUs with limited resources. We sought to compare existing screening tools for the ability to predict falls in the EMU.
The TVB technology enables clinicians to simulate the spread of abnormal activity during epileptic seizures in a patient's brain, helping them to identify the target areas better. The simulations are personalized for each patient, effectively providing a virtual epileptic patient (VEP) tailored to each individual real one.
“We know that agoraphobia can lead to delays in patient care because of a reluctance to go out in public, which includes appointments with health care providers,”
Our findings suggest early activation of endothelium and increased BBB permeability after seizures.
Only approximately half of patients with prolonged seizure-freedom had a documented discussion about antiseizure medication discontinuation. Discontinuation was fairly rare even among low-risk patients.
A study determines the candidacy and treatment for epilepsy surgery in persons with drug-resistant epilepsy (DRE) is not uniform.
